Zantac Recall Lawyers Reviewing Cancer Claims

Austin Kirk

By Austin Kirk
Posted October 9, 2019

ADD YOUR COMMENTS

Recent testing by an independent pharmacy has confirmed that users of Zantac may have been exposed to massive amounts of the human carcinogen N-nitrosodimethylamine (NDMA). This has resulted in nationwide calls for a Zantac recall and lawsuits against the drug makers for failing to warn about this risk.

Contact Our Lawyers To Review a ZANTAC CANCER CLAIM

  • Do You Have a Valsartan Case?
  • Step 1 of 2

Saiontz & Kirk, PA, Attorneys & Lawyers, Baltimore, MD

The product liability lawyers at Saiontz & Kirk, P.A. are reviewing Zantac claims for individuals throughout the United States who were diagnosed with any of the following cancers in recent years, which have been linked to human exposure to NDMA:

  • Bladder Cancer
  • Stomach Cancer
  • Colorectal Cancer
  • Esophageal Cancer
  • Intestinal Cancer
  • Ovarian Cancer
  • Pancreatic Cancer
  • Testicular Cancer
  • Uterine Cancer
  • Liver Cancer
  • Kidney Cancer
  • Other Cancers

Zantac NDMA Contamination

Zantac (ranitidine) was first approved in 1983, for the treatment of heartburn with acid indigestion. It has also been approved for the treatment of stomach ulcers, gastroesophageal reflux disease (GERD) and other stomach acid problems.

Following wide-spread marketing for the drug, which promoted the safety of Zantac, the medication was the first to ever reach $1 billion in annual sales, and has been a top-selling drug for decades. Zantac is now widely available over-the-counter (OTC), and generic ranitidine versions are sold by a number of pharmacies and drug makers.

Last month, CVS, Walmart, Rite-Aid, Walgreens and other prominent pharmacies suspended sales of the drug amid concerns about a potential link between Zantac and cancer. This came following the discovery that tablets manufactured by several different drug makers may contain high levels of the human carcinogen NDMA.

The problem was brought to light by the online pharmacy Valisure, which conducts independent testing on all drugs in its pharmacy. Analysis discovered “extremely high levels of NDMA” in all lots of Zantac tested, across multiple manufacturers and ranitidine products.

On September 9, 2019, Valisure filed a Zantac recall petition (PDF) with the FDA, calling for the drug to be removed from the market throughout the United States.

“The Food and Drug Administration has established a permissible daily intake limit for the probable human carcinogen, NDMA, of 96 ng. Valisure has detected NDMA in excess of 3,000,000 ng per tablet when analyzing ranitidine products, likely due to an inherent instability of the ranitidine molecule.”

The petition presents evidence that the manufacturers knew or should have known about the NDMA risks since Zantac first put on the market, and outlines a number of studies and concerns raised through the years, which were apparently ignored by drug makers.

The petition to recall Zantac also calls for the FDA to make sure consumers are instructed about how to safely get rid of unused pills without contaminating drinking water sources, as dumping the pills in the toilet or into landfills should be avoided. It also called on the FDA to put in place new regulations that require stringent independent chemical testing and verification of pharmaceutical products.

Zantac Claims May Provide Financial Compensation for Cancer Diagnosis

The Zantac recall lawyers at Saiontz & Kirk, P.A. are investigating claims by individuals nationwide who say they developed various forms of cancer following long-term Zantac use, including:

  • Bladder Cancer
  • Stomach Cancer
  • Small Intestine Cancer
  • Colorectal Cancer
  • Esophageal Cancer
  • Liver Cancer
  • Pancreatic Cancer
  • Testicular Cancer
  • Uterine Cancer
  • Kidney Cancer

It appears the drug makers knew for decades that Zantac contained NDMA, a chemical that is known to cause cancer in humans. However, rather than investigating the risk and warning about the side effect of Zantac, the medication was sold as a safe and effective treatment.

If you, a friend or family member have been diagnosed with cancer after at least three months of Zantac use, request a free consultation and claim evaluation. All claims are handled on a contingency fee basis, meaning there are no out-of-pocket expenses and our attorneys receive no fees unless a settlement or court judgment is reached.

REQUEST A ZANTAC CLAIM EVALUATION

No Comments • Add Your Comments

Add Your Comments

  • Have Your Comments Reviewed by a Lawyer

    Provide contact information below and additional private comments if you want an attorney to contact you to review a potential case.

    The information below will not be published to this page.

  • NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

  • This field is for validation purposes and should be left unchanged.